Angiotensin II in Liver Transplantation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.
Epistemonikos ID: 50c4e7ccaca643cc4ff7eed94cd32dc59dc7ad6d
First added on: May 08, 2024